Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03475004
Brief Title: Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer

First Submitted : March 14, 2018
First Submitted that Met QC Criteria : March 21, 2018
First Posted : March 23, 2018

Last Update Submitted that Met QC Criteria : February 19, 2021
Last Update Posted : February 21, 2021